NSEGranting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals2d ago · 23 Sept 2026, 04:10 pm
Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals
IOL Chemicals and Pharmaceuticals Limited · IOLCP
✦ AI Summary▲ PositiveRegulatory
IOL Chemicals and Pharmaceuticals Limited has received REACH certification/registration for its product 'Triacetin' under the EU-REACH framework, enabling the company to export the product across European Union countries.
Analysis Scores
Earnings Impact2/10
Growth Catalyst4/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about EU-REACH Registration for Triacetin
Attachments (1)
📄pdf
Download →
IOLCP_23092026161029_Intimation230926.pdf
View document text
23rd September 2026
IOLCP/CGC/2026
National Stock Exchange of India Ltd BSE Limited
Exchange Plaza, Plot no. C/1, G Block, Phiroze Jeejeebhoy Towers,
Bandra-Kurla Complex, Bandra (E) Dalal Street
Mumbai - 400 051 Mumbai – 400 001
Security Symbol: IOLCP Security Code: 524164
Subject: EU-REACH Registration for Triacetin
Dear Sirs,
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, read with the SEBI Master Circular No. HO/49/14/14(7)2025-CFD-
POD2/I/3762/2026 dated 30th January 2026, we are pleased to inform that the Company has
received REACH certification /registration for its product “Triacetin” under the applicable EU-
REACH framework. This certification enables the Company to export Triacetin across all the
countries in European Union.
This registration further strengthens the Company’s regulatory compliance and market access in
international markets and supports its continued focus on expanding its presence in global markets
through product registrations and regulatory approvals.
Details required under abovesaid SEBI Master Circular is annexed herewith as “Annexure -1”.
This information will also be accessible on the Company’s website: www.iolcp.com.
You are requested to take the above information on record.
Thanking You,
Yours faithfully,
for IOL Chemicals and Pharmaceuticals Limited
Abhay Raj Singh
Sr. Vice President & Company Secretary
Annexure -1
Details required under Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular
No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January 2026, is annexed herewith
Particulars Details
European Chemicals Agency (ECHA) under the EU REACH
a) Name of the regulatory or
(Registration, Evaluation, Authorisation and Restriction of
licensing authority
Chemicals) framework.
The Company has received REACH certification /registration
b) Brief details of the
for its product “Triacetin” under the applicable EU-REACH
approval/license obtained
framework.
The registration enables the Company to Export its product
c) Impact/relevance of such
"Triacetin" in European markets. The registration further
approval/license to the listed
supports the Company’s regulatory compliance and access to
entity
the European market.
d) Withdrawal/cancellation or
Not Applicable.
suspension
The registration is valid in accordance with the applicable
e) Period for which such provisions of the EU REACH Regulation and is subject to
approval/license is/was valid continued compliance with the applicable regulatory
requirements.
f) Subsequent actual
Not Applicable,
impact/corrective actions